CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0770

4-Piperidone CAS 41661-47-6

Filed under Raw Materials. The bureau holds 123 laboratory returns for this compound from 39 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

39 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 5 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
BachemCASE #VI-2026-0314 A 4 10.0 9.9 10.0 23 Jan 2026 6 May 2026
Hubei JianxiangCASE #VI-2026-0048 A 4 10.0 9.9 10.0 20 Mar 2026 19 Jun 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 4 10.0 9.9 10.0 15 Dec 2025 20 Jun 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 4 10.0 10.0 10.0 9 May 2026 26 Jun 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 4 10.0 9.9 10.0 9 May 2026 8 Jul 2026
AsymchemCASE #VI-2026-0091 A 4 10.0 9.9 10.0 20 Jan 2026 15 May 2026
Sangon BioCASE #VI-2026-0671 A 3 10.0 9.9 10.0 10 Dec 2025 20 Feb 2026
Kerui PeptidesCASE #VI-2026-0626 A 3 10.0 9.9 10.0 5 Jan 2026 10 Jun 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 3 10.0 9.9 10.0 4 Feb 2026 24 Jun 2026
Sigma-AldrichCASE #VI-2026-0829 A 3 10.0 10.0 10.0 20 Apr 2026 26 Jul 2026
AmbioPharmCASE #VI-2026-0177 A 3 10.0 9.9 10.0 26 Jul 2026 13 Aug 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 10.0 10.0 10.0 9 Mar 2026 15 Mar 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 10.0 10.0 10.0 22 Apr 2026 6 May 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 2 10.0 10.0 10.0 26 Jul 2026 7 Aug 2026
SinoPepCASE #VI-2026-0387 A 2 10.0 10.0 10.0 11 Apr 2026 12 Aug 2026
Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 X 1 10.0 10.0 10.0 9 Jun 2025 9 Jun 2025
Paradigm PeptideCASE #VI-2026-0759 X 1 10.0 10.0 10.0 13 Feb 2025 13 Feb 2025
HomopeptideCASE #VI-2026-0760 A 4 9.9 9.9 10.0 23 May 2026 23 May 2026
QYAOBIOCASE #VI-2026-0861 A 4 9.9 9.9 10.0 10 Feb 2026 24 May 2026
JEEP PeptidesCASE #VI-2026-0457 A 4 9.9 9.9 10.0 24 Jan 2026 7 Jul 2026
WuXi TIDESCASE #VI-2026-0335 A 4 9.9 9.9 10.0 14 Jan 2026 13 Jun 2026
PolyPeptide GroupCASE #VI-2026-0143 A 4 9.9 9.9 10.0 4 Apr 2026 2 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 3 9.9 9.9 10.0 26 Mar 2026 26 Jun 2026
GenScript PeptidesCASE #VI-2026-0860 A 2 9.9 9.9 10.0 3 Apr 2026 9 Aug 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 6 9.2 6.9 10.0 24 May 2026 24 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 5 9.1 7.3 9.9 24 May 2026 24 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 3 9.0 8.1 10.0 24 May 2026 24 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 8 8.5 7.1 10.0 24 May 2026 24 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 4 8.4 7.4 9.3 24 May 2026 24 May 2026
Peptide CraftersCASE #VI-2026-0994 X 2 7.6 6.9 8.3 20 Jun 2025 24 May 2026
Reta-PeptideCASE #VI-2026-0756 X 9 7.4 6.0 8.7 20 Jun 2025 17 May 2026
M-PeptidesCASE #VI-2026-0442 X 1 7.4 7.4 7.4 21 May 2025 21 May 2025
PeptiAtlasCASE #VI-2026-0739 X 1 7.2 7.2 7.2 2 Apr 2025 2 Apr 2025
Xingtai Pukelai Technology CoCASE #VI-2026-0850 X 1 7.2 7.2 7.2 7 May 2025 7 May 2025
Haikou Mingheng BiotechnologyCASE #VI-2026-0126 X 1 6.9 6.9 6.9 11 Jun 2025 11 Jun 2025
Richards Biotech Simply RichardsCASE #VI-2026-0307 X 1 6.5 6.5 6.5 24 Apr 2025 24 Apr 2025
Coffee and PeppersCASE #VI-2026-0274 X 1 1.1 1.1 1.1 24 Apr 2025 24 Apr 2025
HK Fat CatCASE #VI-2026-0376 X 1 0.0 0.0 0.0 27 Feb 2025 27 Feb 2025

Open any subject to view the batch-level evidence for 4-Piperidone CAS 41661-47-6 alone.